Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s innovative drug development initiative-Group 3 pulmonary hypertension
Related Posts
Lauria M, Miller C, Singhrao K, Lewis J, Lin W, O'Connell D, Naumann L, Stiehl B, Santhanam A, Boyle P, Raldow AC, Goldin J, Barjaktarevic[...]
Casaburi R. In-Home Pulmonary Rehabilitation - A Critical Review of the Supporting Evidence. Respir Care. 2024 Mar 26:respcare.11785. doi: 10.4187/respcare.11785. Epub ahead of print. PMID:[...]
Gaylis NB, Yang OO. Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC) - The hunt for effective treatments. J Infect. 2024 Mar 24:106146. doi:[...]